Evidence map›Paper›PMID 38675613›Full record

ReviewMolecules (Basel, Switzerland)2024

Saponins of

Luyao Li, Jiachan Zhang, Wenjing Cheng, Feiqian Di, Changtao Wang, Quan An

Open access · goldAbstract readReview
In one paragraph

Review in Molecules (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
12.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Frontiers in pharmacology · 2025
    Review
  12. Review
  13. Frontiers in pharmacology · 2025
    Review
  14. Review
  15. Article
  16. Phytochemicals, promising strategies combatingFrontiers in pharmacology · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Luyao LiCollege of Light Industry Science and Engineering, Beijing Technology & Business University, Beijing 100048, China.
Jiachan ZhangCollege of Light Industry Science and Engineering, Beijing Technology & Business University, Beijing 100048, China.ORCID 0000-0003-3990-0471
Wenjing ChengCollege of Light Industry Science and Engineering, Beijing Technology & Business University, Beijing 100048, China.
Feiqian DiCollege of Light Industry Science and Engineering, Beijing Technology & Business University, Beijing 100048, China.
Changtao WangCollege of Light Industry Science and Engineering, Beijing Technology & Business University, Beijing 100048, China.
Quan AnYunnan Baiyao Group Co., Ltd., Kunming 650000, China.
Beijing Technology and Business University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Acne is a chronic inflammatory skin disease with a recurring nature that seriously impacts patients' quality of life. Currently, antibiotic resistance has made it less effective in treating acne. However,

Indexed as

Acne VulgarisAnti-Bacterial AgentsAnti-Inflammatory AgentsAntioxidantsSaponinsAnimalsHumansImmunologic FactorsImmunomodulating AgentsLiliaceaeMelanthiaceaePlant ExtractsAnti-Bacterial AgentsAnti-Inflammatory AgentsAntioxidantsImmunologic FactorsImmunomodulating AgentsPlant ExtractsSaponinsacneantibacterialanti-inflammatoryextraction processimmunomodulatoryP. polyphylla saponin

Identifiers

PMID38675613
PMCPMC11052371
OpenAlexW4394799060

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.